Pneumonia, Pneumocystis: Clinical Trials

107 trials for Pneumonia, Pneumocystis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

73 completed, 14 unknown, 8 recruiting, 5 not yet recruiting. 29 Not applicable, 26 Phase 3, 9 Phase 4, 8 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable29Completed 27, Enrolling by invitation 1, Unknown 1
Phase 326Completed 17, Terminated 3, Unknown 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 49Not yet recruiting 3, Completed 2, Unknown 2, Recruiting 1, Withdrawn 1
Phase 18Completed 7, Recruiting 1
Phase 28Completed 4, Recruiting 2, Terminated 1, Unknown 1
Early Phase 11Unknown 1

Follow Pneumonia, Pneumocystis: new trials by email Literature Review of Pneumonia, Pneumocystis trials Research Report on Pneumonia, Pneumocystis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney Transplantation
Trimethoprim-Sulfamethoxazole (TMP-SMX) - Pneumocystis Jirovecii Pneumonia, Kidney Transplantation
Phase 4Not yet recruitingAnhui Provincial Hospital10842026-06-012026-06-01
Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)
Clindamycin + primaquine, Pentamidine, Atovaquone - Pneumocystis, Pneumocystis Infection
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-03-012026-01-21
How Long Should we Give Steroids for Patients With Severe PCP
Systemic corticosteroids - Pneumocystis Pneumonia, Pneumocystis
Phase 4Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162026-01-302026-01-09
CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis Pneumonia
Caspofungin Acetate 50 MG, Physiologic saline - Pneumocystis Pneumonia, Pneumocystis Jirovecii Infection
Phase 1 / Phase 2RecruitingUniversity Hospital, Tours1002025-12-022026-10-09
Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia
trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia
Phase 3RecruitingTodd C. Lee MD MPH FIDSA4162025-11-282026-02-20
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Corticosteroids for PJP in Non-HIV Immunocompromised Adults
Saline (0.9%, sterile, for infusion), Low Dose Corticosteroids, Moderate dose corticosteroids - Pneumocystis Jiroveci Pneumonia
Phase 3Not yet recruitingQingyuan Zhan2402025-09-082025-09-09
Pneumocystis Jirovecii Genotyping
Pneumocystis Pneumonia
Not yet recruitingNottingham University Hospitals NHS Trust702025-09-012025-06-27
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
Biological sampling - Pneumocystis, Immunocompromised Patients
RecruitingAssistance Publique - Hôpitaux de Paris2402025-07-082026-04-23
Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)
Beta-1,3/1,6-D-Glucan - Candidemia, Aspergillosis Invasive
CompletedCentral Hospital, Nancy, France2802024-12-172025-12-09
Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic Disease
Trimethoprim/Sulfamethoxazole - Pneumonia, Pneumocystis, Autoimmune Inflammatory Rheumatic Disease
Phase 4RecruitingTongji Hospital8002024-07-202024-10-01
Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis Jirovecii
Pneumocystis Pneumonia
Active not recruitingUniversity Hospital, Brest3002024-06-012024-08-09
Rezafungin for Treatment of Pneumocystis Pneumonia in HIV Adults
Co-Trimoxazole, Rezafungin Acetate / Co Trimoxazole - Pneumocystis Pneumonia
Phase 2RecruitingMundipharma Research Limited502023-11-142025-04-03
Introduction of Polymerase Chain Reaction (PCR) in Microbiology and Parasitology
Malaria, Pneumocystis, Leishmania
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia2002023-09-012025-12-08
Caspofungin for Pneumocystis Pneumonia in PLWHIV.
HIV-1-infection, Pneumocystis Pneumonia
RecruitingInstituto Nacional de Enfermedades Respiratorias602023-08-012024-11-19
Prospective Observational Study on the Incidence of Opportunistic Fungal Infections
Pneumocystis Jirovecii Infection, Pneumocystis
CompletedUniversity of Colorado, Denver120322023-07-052025-04-02
Radiomics Model for the Diagnosis of Pneumocystis Jirovecii Pneumonia in Non-HIV Patients
Radiomic model - Pneumocystis Jirovecii Pneumonia
UnknownChinese PLA General Hospital1402023-01-152023-01-27
Factors Associated With Survival in Patients Having Pneumocystis Jirovecii
Pneumocystis Jirovecii Infection
UnknownUniversity Hospital, Strasbourg, France3002023-01-012023-12-15
PCP in Immunocompromised Population in Southern China
PCR was used to detect pneumocystis in respiratory specimens - Immunocompromised Patients, Pneumocystis Pneumonia
UnknownFirst Affiliated Hospital of Guangxi Medical University3002021-05-122022-11-04
Comprehensive Diagnosis and Treatment Strategy for Opportunistic Fungal Infections in AIDS Patients
examination methods - Opportunistic Fungal Infections
UnknownGuangzhou 8th People's Hospital6002021-04-012021-12-13

Showing 20 of 107. Sign in to see all of them.

Narrower conditions

HIV Infections (59)  ·  Acquired Immunodeficiency Syndrome (55)  ·  AIDS-Related Opportunistic Infections (30)  ·  AIDS-Related Complex (16)  ·  Pneumonia (10)  ·  Pneumocystis Infections (8)  ·  Respiratory Aspiration (7)  ·  Infections (5)  ·  Mycoses (4)  ·  COVID-19 (3)  ·  Invasive Pulmonary Aspergillosis (3)  ·  Aspergillosis (2)  ·  Candidemia (2)  ·  Candidiasis (2)

Broader conditions

Bacterial Infections and Mycoses (107)  ·  Respiratory Tract Diseases (107)  ·  Lung Diseases (106)  ·  Lung Diseases, Fungal (106)  ·  Respiratory Tract Infections (106)  ·  Mycoses (103)  ·  Infections (102)  ·  Pneumocystis Infections (99)  ·  Pneumonia (97)  ·  RNA Virus Infections (65)  ·  Virus Diseases (65)  ·  Immune System Diseases (64)  ·  Blood-Borne Infections (62)  ·  Communicable Diseases (62)  ·  Genital Diseases (62)

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination (23)  ·  Pentamidine (22)  ·  Leucovorin (13)  ·  trimetrexate glucuronate (12)  ·  Atovaquone (10)  ·  Dapsone (10)  ·  Zidovudine (7)  ·  Methylprednisolone (5)  ·  Trimethoprim (5)  ·  Clindamycin (4)  ·  Primaquine (4)  ·  Sulfamethoxazole (4)  ·  Adrenal Cortex Hormones (3)  ·  Caspofungin (3)  ·  8-aminoquinoline (2)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (36)  ·  Fisons (5)  ·  U.S. Bioscience (5)  ·  Glaxo Wellcome (4)  ·  Assistance Publique - Hôpitaux de Paris (2)  ·  Central Hospital, Nancy, France (2)  ·  Jacobus Pharmaceutical (2)  ·  LyphoMed (2)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (2)  ·  Mundipharma Research Limited (2)  ·  Peking Union Medical College Hospital (2)  ·  Rennes University Hospital (2)  ·  Shanghai Public Health Clinical Center (2)  ·  University of Pittsburgh (2)  ·  Abbott (1)

Countries

United States (62)  ·  France (15)  ·  China (11)  ·  Puerto Rico (7)  ·  Belgium (4)  ·  Canada (4)  ·  Tanzania (4)  ·  Germany (3)  ·  Italy (3)  ·  Mexico (2)  ·  South Africa (2)  ·  United Kingdom (2)  ·  Botswana (1)  ·  Brazil (1)  ·  Denmark (1)

Top investigators

Feinberg J (5)  ·  Alison Morris-Gimbel, MD (2)  ·  B Montgomery (2)  ·  Black JR (2)  ·  El-Sadr W (2)  ·  Emily G McDonald, MD MSc (2)  ·  Fischl M (2)  ·  Frame P (2)  ·  Luskin-Hawk R (2)  ·  Masur H (2)  ·  Ptachcinski R (2)  ·  Sattler FR (2)

Results publications

PMID 41151592, PMID 15504856, PMID 16304338, PMID 18046534, PMID 18230259, PMID 20607114, PMID 20946413, PMID 21732834, PMID 22548840, PMID 23940606, PMID 25603113, PMID 26872154, PMID 26935726, PMID 29313714, PMID 29514207, PMID 30776290, PMID 31548210, PMID 31633150, PMID 32194238, PMID 32391667, PMID 32479781, PMID 32653726, PMID 32671131, PMID 33005696, PMID 33213011, PMID 33438477, PMID 33538349, PMID 33586013, PMID 34349985, PMID 34682270, PMID 34682277, PMID 34843666, PMID 34988242, PMID 35602475, PMID 35657109, PMID 35863836, PMID 36803640, PMID 37541984, PMID 37656874, PMID 37773627, PMID 38167022, PMID 38235979, PMID 40652952, PMID 42558999, PMID 9872631

NIH funding

2016 (1), 2017 (1), 2023 (1), R01HL083461 (1), R01HL090339 (1), U01AI068632 (1)